NCT01943682View on ClinicalTrials.gov

Safety Study of CPX-351 in Children With Relapsed Leukemia or Lymphoma

PHASE1CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

March 31, 2019

Study Completion Date

April 30, 2019

Conditions
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaBurkitt LymphomaDiffuse Large Cell LymphomaGray Zone LymphomaLymphoblastic LymphomaAnaplastic Large Cell LymphomaHodgkin Lymphoma
Interventions
DRUG

CPX-351

Comparison of Different doses of drug

Trial Locations (1)

45229

Cincinnati Children's Hospital Medical Center, Cincinnati

Sponsors

Collaborators (1)

Jazz Pharmaceuticals
All Listed Sponsors
collaborator

Jazz Pharmaceuticals

INDUSTRY

lead

Children's Hospital Medical Center, Cincinnati

OTHER